The Kingston Report

The Kingston Report

Pfizer Brings US BioPharma Investment to More than $230 Billion By 2030

As much as we love to hate the BioPharma industry, especially Pfizer, Trump just solved a multi-decade problem for both the industry and the American people.

Karen Kingston's avatar
Karen Kingston
Oct 01, 2025
∙ Paid

September 30, 2025: Yesterday, President Trump, HHS Secretary Kennedy, CMS Administrator Dr. Oz, and Pfizer CEO Albert Bourla announced an agreement in which Pfizer would be investing $70 billion in US research & development, manufacturing, and other areas over the next few years.

Pfizer’s milestone investments of the $70 billion will bring US BioPharma…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Karen Kingston
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture